Wednesday, November 16, 2016
Print Current Session:
|
|
Wednesday
SESSION 32:
DRUG RESISTANT HYPERTENSION AND ITS CATHETER-BASED TREATMENTS; MEDICAL TREATMENTS; FRACTIONAL FLOW RESERVE; ASSESSMENT OF AAA RISK; UNUSUAL VASCULAR DISEASES
Moderators:Ron Waksman, MD / Anthony J. Comerota, MD, FACS, FACC
|
|
SESSION 32 SCHEDULE | |
7:46 AM - 7:51 AM | Why Pharmacological Treatments Are Insufficient To Control Hypertension In Some Patients And What Is The Outlook For Non-Pharmacologic Treatments; Renal Denervation And Baroreflex Stimulation (Neostim) And Modulation (Mobius) |
Presenter(s):Melvin D. Lobo, MBChB , PhD, FRCP, FBHS, FESC | |
View Slides in PDF | |
7:52 AM - 7:57 AM | What Is New With Endovascular Treatments Of Drug Resistant Hypertension: New Better Devices Like The Peregrine And Paradise Systems For Renal Denervation: New Study Results: Future Predictions |
Presenter(s):Horst Sievert, MD | |
View Slides in PDF | |
7:58 AM - 8:03 AM | Renal Artery Denervation For Hypertension: Why Hasn’t It Worked And Where Is It Going |
Presenter(s):Krishna J. Rocha-Singh, MD | |
View Slides in PDF | |
8:04 AM - 8:09 AM | Update On The ROX Endovascular System For Creating An Iliac A-V Fistula To Treat Resistant Hypertension: How It Works, Results And Complications |
Presenter(s):David H. Deaton, MD, FACS | |
View Slides in PDF | |
8:10 AM - 8:15 AM | Diagnostic Strategy For Children With Suspected Renin Mediated Hypertension Is Multimodal: Is Endovascular Treatment Ever Effective |
Presenter(s):Kyung Cho, MD | |
View Slides in PDF | |
8:16 AM - 8:21 AM | What’s New In The Pharmacologic Prevention And Treatment In Patients With Arteriosclerotic Vascular Disease – Where Are We Currently With Statins, PCSK 9 Inhibitors And Platelet Inhibitors |
Presenter(s):Iris Baumgartner, MD | |
View Slides in PDF | |
8:22 AM - 8:27 AM | Update On The Value Of Coronary CT And Fractional Flow Reserve (FFRct): Does It Eliminate Unnecessary Coronary Angiograms And Stents; Will The Technique Work In The Lower Extremity |
Presenter(s):Christopher K. Zarins, MD | |
View Slides in PDF | |
8:28 AM - 8:33 AM | How Skin Biopsy Can Predict AAA Growth Rates And Rupture |
Presenter(s):Kak Khee Yeung, MD, PhD | |
View Slides in PDF | |
8:34 AM - 8:39 AM | Systemic Inflammatory Disease: What Is It And How To Diagnose It: Does It Predict Increase Risk Of Post EVAR Complications, Type 2 Endoleak And Rupture |
Presenter(s):Alan Dardik, MD, PhD | |
View Slides in PDF | |
8:40 AM - 8:45 AM | Segmental Arterial Mediolysis: What Is It; What Is Its Clinical Significance; How To Diagnose And Treat It |
Presenter(s):Samuel R. Money, MD, MBA | |
View Slides in PDF | |
8:46 AM - 8:54 AM | Panel Discussion |
END OF SESSION 32 | |
previous | next |